A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

Episialin (MUC1, PEM, EMA, CA15-3 antigen) is a sialylated, membrane-associated glycoprotein with an extended mucin-like ectodomain. This domain mainly consists of 30-90 homologous 20-amino acid repeats that are rich in O-glycosylation sites (serines and threonines). It is likely that this part forms a polyproline beta-turn helix. As a result, the ectodomain can protrude more than 200 nm above the cell surface, whereas most cell surface molecules do not exceed a length of 35 nm. Normally, episialin is present at the apical side of glandular epithelial cells. On carcinoma cells, however, it can be strongly overexpressed and it is often present over the entire cell surface. We have previously shown that episialin, if it is interspersed between adhesion molecules, nonspecifically reduces cell-cell and cell-extracellular matrix interactions in vitro and in vivo, presumably by steric hindrance caused by the extreme length and high density of the episialin molecules at the cell surface. To analyze the molecular mechanism for this anti-adhesion effect in more detail, we have now deleted an increasing number of repeats in the episialin cDNA and transfected the resulting mutants into murine L929 cells expressing the homophilic adhesion molecule E-cadherin. Here we show that the length of episialin is the dominant factor that determines the inhibition of E-cadherin-mediated cell-cell interactions. For the anti-adhesive effect mediated by the full length episialin, charge repulsion by negatively charged sialylated O-linked glycans is far less important.     

Test-Retest Reliability of Innovated Strength Tests for Hip Muscles

The burden of hip muscles weakness and its relation to other impairments has been well documented. It is therefore a pre-requisite to have a reliable method for clinical assessment of hip muscles function allowing the design and implementation of a proper strengthening program. Motor-driven dynamometry has been widely accepted as the gold-standard for lower limb muscle strength assessment but is mainly related to the knee joint. Studies focusing on the hip joint are less exhaustive and somewhat discrepant with regard to optimal participants position, consequently influencing outcome measures. Thus, we aimed to develop a standardized test setup for the assessment of hip muscles strength, i.e. flexors/extensors and abductors/adductors, with improved participant stability and to define its psychometric characteristics. Eighteen participants performed unilateral isokinetic and isometric contractions of the hip muscles in the sagittal and coronal plane at two separate occasions. Peak torque and normalized peak torque were measured for each contraction. Relative and absolute measures of reliability were calculated using the intraclass correlation coefficient and standard error of measurement, respectively. Results from this study revealed higher levels of between-day reliability of isokinetic/isometric hip abduction/flexion peak torque compared to existing literature. The least reliable measures were found for hip extension and adduction, which could be explained by a less efficient stabilization technique. Our study additionally provided a first set of reference normalized data which can be used in future research.     

Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study

BackgroundCystic Fibrosis (CF) is characterized by chronically inflamed airways, and inflammation even increases during pulmonary exacerbations. These adverse events have an important influence on the well-being, quality of life, and lung function of patients with CF. Prediction of exacerbations by inflammatory markers in exhaled breath condensate (EBC) combined with early treatment may prevent these pulmonary exacerbations and may improve the prognosis.AimTo investigate the diagnostic accuracy of a set of inflammatory markers in EBC to predict pulmonary exacerbations in children with CF.MethodsIn this one-year prospective observational study, 49 children with CF were included. During study visits with an interval of 2 months, a symptom questionnaire was completed, EBC was collected, and lung function measurements were performed. The acidity of EBC was measured directly after collection. Inflammatory markers interleukin (IL)-6, IL-8, tumor necrosis factor α (TNF-α), and macrophage migration inhibitory factor (MIF) were measured using high sensitivity bead based flow immunoassays. Pulmonary exacerbations were recorded during the study and were defined in two ways. The predictive power of inflammatory markers and the other covariates was assessed using conditionally specified models and a receiver operating characteristic curve (SAS version 9.2). In addition, k-nearest neighbors (KNN) algorithm was applied (SAS version 9.2).ResultsSixty-five percent of the children had one or more exacerbations during the study. The conditionally specified models showed an overall correct prediction rate of 55%. The area under the curve (AUC) was equal to 0.62. The results obtained with the KNN algorithm were very similar.ConclusionAlthough there is some evidence indicating that the predictors outperform random guessing, the general diagnostic accuracy of EBC acidity and the EBC inflammatory markers IL-6, IL-8, TNF-α and MIF is low. At present it is not possible to predict pulmonary exacerbations in children with CF with the chosen biomarkers and the method of EBC analysis. The biochemical measurements of EBC markers should be improved and other techniques should be considered.     

Non-rigid deformation to include subject-specific detail in musculoskeletal models of CP children with proximal femoral deformity and its effect on muscle and contact forces during gait

To account for proximal femoral deformities in children with cerebral palsy (CP), subject-specific musculoskeletal models are needed. Non-rigid deformation (NRD) deforms generic onto personalized bone geometry and thereby transforms the muscle points. The goal of this study was to determine to what extent the models and simulation outcomes in CP patients differ when including subject-specific detail using NRD or Magnetic Resonance Imaging (MRI)-based models. The NRD models slightly overestimated hip contact forces compared to MRI models and differences in muscle point positions and moment arm lengths (MALs) remained, although differences were smaller than for the generic model.     

Identification of a novel process limiting the rate of synaptic vesicle cycling at hippocampal synapses

During intense presynaptic activity, the readily releasable pool (RRP) of synaptic vesicles empties more quickly than it can be refilled, and short-term depression results. Ordinarily, the pool refills within 20 s, but long, high-frequency trains of action potentials often induce a form of short-term depression that persists for a much longer time. Here, we report that replenishment of the RRP is governed by two simple processes: the previously identified mechanism termed refilling, and another process that appears after extensive exocytosis and produces a transient decrease in the capacity of the pool, lasting for several minutes. The data presented here place stringent constraints on the types of kinetic models that can be used to describe synaptic vesicular cycling and are inconsistent with the traditional multipool models of vesicular mobilization.     

Exopolyphosphatases PPX1 and PPX2 from Corynebacterium glutamicum

Corynebacterium glutamicum accumulates up to 300 mM of inorganic polyphosphate (PolyP) in the cytosol or in granules. The gene products of cg0488 (ppx1) and cg1115 (ppx2) were shown to be active as exopolyphosphatases (PPX), as overexpression of either gene resulted in higher exopolyphosphatase activities in crude extracts and deletion of either gene with lower activities than those of the wild-type strain. PPX1 and PPX2 from C. glutamicum share only 25% identical amino acids and belong to different protein groups, which are distinct from enterobacterial, archaeal, and yeast exopolyphosphatases. In comparison to that in the wild type, more intracellular PolyP accumulated in the Δppx1 and Δppx2 deletion mutations but less when either ppx1 or ppx2 was overexpressed. When C. glutamicum was shifted from phosphate-rich to phosphate-limiting conditions, a growth advantage of the deletion mutants and a growth disadvantage of the overexpression strains compared to the wild type were observed. Growth experiments, exopolyphosphatase activities, and intracellular PolyP concentrations revealed PPX2 as being a major exopolyphosphatase from C. glutamicum. PPX2^His was purified to homogeneity and shown to be active as a monomer. The enzyme required Mg²⁺ or Mn²⁺ cations but was inhibited by millimolar concentrations of Mg²⁺, Mn²⁺, and Ca²⁺. PPX2 from C. glutamicum was active with short-chain polyphosphates, even accepting pyrophosphate, and was inhibited by nucleoside triphosphates.Inorganic polyphosphate (PolyP), a linear polymer made of up to hundreds of orthophosphate residues (P_i), has been found in all organisms tested for its presence (3, 4, 7, 12, 20, 22, 48). In nature''s phosphorus cycle, diatom-derived PolyP has recently been shown to be critically important for marine phosphorus sequestration (6). In cells, PolyP may function as a means of storage of phosphorus and/or energy, may substitute ATP in kinase reactions, and was shown to be important in response to many stresses. Mutants of Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp., Vibrio cholerae, and Helicobacter pylori with a low PolyP content showed defects in environmental stress responses and/or virulence (2, 14, 17, 38). In amino acid-starved E. coli, PolyP accumulates and is bound by Lon protease, which degrades ribosomal proteins to liberate amino acids (23).The presence of PolyP granules is used as a diagnostic criterion to distinguish the pathogenic Corynebacterium diphtheriae from nonpathogenic corynebacteria, such as Corynebacterium glutamicum (54). However, these metachromatic granules have recently been shown to be present also in nonpathogenic C. glutamicum (33). When sufficient phosphate is available, C. glutamicum accumulates up to 300 mM of PolyP (24) either soluble in the cytosol or in volutin granules (18, 33). During growth of C. glutamicum on glucose, intracellular PolyP concentrations peaked in the early exponential growth phase and at the entry to stationary phase (18). Soluble PolyP prevailed in the stationary growth phase, while PolyP occurred in granules in the early exponential growth phase (18). C. glutamicum is widely used for the biotechnological production of about 2,200,000 tons of amino acids per year, mainly l-glutamate and l-lysine (50, 58), while the related Corynebacterium ammoniagenes is used for the production of the flavor-enhancing purine nucleotides IMP and XMP (30). As it is conceivable that engineering corynebacterial PolyP metabolism affects overproduction of amino acids or of the phosphorus-containing compounds IMP and XMP, the study of PolyP metabolism and the enzymes involved has recently received increasing attention.PolyP formation in C. glutamicum was shown to be stimulated by MgCl₂ (33), probably due to the magnesium dependence of PolyP synthesizing enzymes (27). In microorganisms, PolyP may be synthesized by PolyP kinases belonging to three distinct families (PPK1, PPK2, and PPK3; EC 2.7.4.1) from ATP or other nucleoside triphosphates (NTPs) in a reversible reaction (12). C. glutamicum possesses two PPK2 genes (ppk2A and ppk2B) (27). Purified PPK2B of C. glutamicum is active as a homotetramer and shows higher catalytic efficiency in the PolyP-forming direction than in the reverse direction, forming NTPs from PolyP. The intracellular PolyP content was increased by overexpression of ppk2B and decreased in the absence of PPK2B (27). Besides PPK2B, no other PolyP-dependent enzyme has been characterized in C. glutamicum, although the cg2091 gene product, a putative PolyP-dependent glucokinase (EC 2.7.1.63), was found to be associated with PolyP granules (33).Degradation of PolyP by hydrolysis may be catalyzed by exopolyphosphatases (PPX) (EC 3.6.1.11) and/or endopolyphosphatases (PPN) (EC 3.6.1.10) (1, 49). Exopolyphosphatases hydrolyze PolyP from the chain''s termini, liberating P_i. The C. glutamicum genome contains two genes encoding putative exopolyphosphatases (ppx1-cg0488 and ppx2-cg1115) (15), but their functions have not yet been characterized. The corresponding proteins are distinct from each other as they share only 25% identical amino acids. Both proteins show 25% amino acid identity to E. coli PPX (1), which possesses 200 additional C-terminal amino acids (56). Here, we have analyzed PolyP degradation in C. glutamicum and show that both cg0488 (ppx1) and cg1115 (ppx2) gene products are functional exopolyphosphatases. Growth experiments, determination of exopolyphosphatase activities, and intracellular PolyP concentrations in strains lacking or overexpressing these genes revealed that cg1115 (ppx2) encodes the major exopolyphosphatase of C. glutamicum, which was characterized enzymatically.     

Augmentation is a potentiation of the exocytotic process

Short-term synaptic enhancement is caused by an increase in the probability with which synaptic terminals release transmitter in response to presynaptic action potentials. Since exocytosed vesicles are drawn from a readily releasable pool of packaged transmitter, enhancement must result either from an increase in the size of the pool or an elevation in the fraction of releasable vesicles that undergoes exocytosis with each action potential. We show here that at least one major component of enhancement, augmentation, is not caused by an increase in the size of the readily releasable pool but is instead associated with an increase in the efficiency with which action potentials induce the exocytosis of readily releasable vesicles.